PHARMASTRAT CONSULTING APS: Financial statements 2024
CVR: 43346318
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMASTRAT CONSULTING APS (CVR 43346318) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,613 and a net result of DKK -3,991 compared with DKK 1,787,613 the year before. Equity in the 2024 report amounted to DKK 2,590,750. The solvency ratio was 95.8%.
- Gross Profit
- DKK -14,613
- Profit/Loss
- DKK -3,991
- Equity
- DKK 2,590,750
- Total Assets
- DKK 2,705,240
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -15K | -4K | 2.6M | 0 |
| 2023 | - | -8K | 1.8M | 2.7M | - |
| 2022 | - | 260K | 25K | 907K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMASTRAT CONSULTING APS has published its annual report for 2023. Gross profit came to DKK -7,925, and the net result was DKK 1,787,613.
About PHARMASTRAT CONSULTING APS
PHARMASTRAT CONSULTING APS is a Danish company of the type Anpartsselskab based in København SV, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nicolas Clément Tipsmark Bouchet. The company is owned by Nicolas Clément Tipsmark Bouchet. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,120 and a net result of DKK -29,821 compared with DKK -3,991 the year before. Equity in the 2025 report amounted to DKK 2,470,929.